首页 | 本学科首页   官方微博 | 高级检索  
     


Omentin and visfatin in adolescent inpatients with anorexia nervosa; association with symptoms
Affiliation:1. Endocrinology and Metabolism Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran;2. Physiology Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences. Kerman, Iran;3. Neuroscience Research Center, Institute of neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran;4. Department of Biology, Faculty of Sciences, Shahid Bahonar University. Kerman, Iran;5. Physiology-Pharmacology Research Center, Research Institute of Basic Medical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran;6. College of Medicine-Phoenix, University of Arizona, Child Health, Phoenix, USA;7. BARROW Neurological Institute at Phoenix Children’s Hospital, Phoenix Children’s Hospital, Phoenix, USA;8. Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Lebanon;9. Departments of Biology, Science and Research Branch, Islamic Azad University. Tehran, Iran
Abstract:Anorexia nervosa (AN) is associated with significant weight loss; thus, it is crucial to discern the contribution of hormones produced by adipose tissue. Some of the adipokines have not been sufficiently studied. Therefore, the present study aims to measure serum concentrations of omentin and visfatin, in adolescent inpatients with AN. The correlations between selected adipokines and psychopathological symptoms of AN were also analyzed.Thirty adolescent inpatients with anorexia nervosa and thirty healthy age and height matched girls (CONT) were enrolled in the study. The physical and mental examination, anthropometric and psychometric assessment - Beck Depression Inventory (BDI), Hamilton Depression Rating Scale (HDRS), Eating Attitude Test (EAT-26) and Yale-Brown Obsessive-Compulsive Scale (YBOCS), and blood analysis were performed at two-time points – in the malnourished patients (AN T1) and after partial weight recovery (8.30 ± 3.75 weeks) (AN T2).The omentin concentration was not significantly different from the CONT neither in AN T1 nor AN T2. The visfatin level was altered in AN T1 and did not change after partial weight normalization (AN T2). A positive correlation between visfatin and YBOCS was found in AN T2.Visfatin concentrations were decreased in adolescent inpatients suffering from AN in the acute phase of the disease and did not normalize after partial weight restoration. The studies considering visfatin as a biomarker of the acute phase of AN should be continued. Moreover, the visfatin showed association with the obsessive and compulsive symptoms; thus its participation in non-homeostatic regulation of food intake should be investigated in further studies.
Keywords:
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号